Show simple item record

dc.contributor.authorCalligaris, David
dc.contributor.authorHornburg, Kalvis
dc.contributor.authorChiocca, E. Antonio
dc.contributor.authorAgar, Nathalie Y. R.
dc.contributor.authorLawler, Sean E.
dc.contributor.authorCho, Choi-Fong
dc.contributor.authorWolfe, Justin
dc.contributor.authorFadzen, Colin M.
dc.contributor.authorPentelute, Bradley L.
dc.date.accessioned2018-02-06T14:57:33Z
dc.date.available2018-02-06T14:57:33Z
dc.date.issued2017-06
dc.date.submitted2016-09
dc.identifier.issn2041-1723
dc.identifier.urihttp://hdl.handle.net/1721.1/113429
dc.description.abstractCulture-based blood-brain barrier (BBB) models are crucial tools to enable rapid screening of brain-penetrating drugs. However, reproducibility of in vitro barrier properties and permeability remain as major challenges. Here, we report that self-Assembling multicellular BBB spheroids display reproducible BBB features and functions. The spheroid core is comprised mainly of astrocytes, while brain endothelial cells and pericytes encase the surface, acting as a barrier that regulates transport of molecules. The spheroid surface exhibits high expression of tight junction proteins, VEGF-dependent permeability, efflux pump activity and receptor-mediated transcytosis of angiopep-2. In contrast, the transwell co-culture system displays comparatively low levels of BBB regulatory proteins, and is unable to discriminate between the transport of angiopep-2 and a control peptide. Finally, we have utilized the BBB spheroids to screen and identify BBB-penetrant cell-penetrating peptides (CPPs). This robust in vitro BBB model could serve as a valuable next-generation platform for expediting the development of CNS therapeutics.en_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/NCOMMS15623en_US
dc.rightsCreative Commons Attribution 4.0 International Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.sourceNatureen_US
dc.titleBlood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agentsen_US
dc.typeArticleen_US
dc.identifier.citationCho, Choi-Fong et al. “Blood-Brain-Barrier Spheroids as an in Vitro Screening Platform for Brain-Penetrating Agents.” Nature Communications 8 (June 2017): 15623 © 2017 The Author(s)en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.mitauthorCho, Choi-Fong
dc.contributor.mitauthorWolfe, Justin
dc.contributor.mitauthorFadzen, Colin M.
dc.contributor.mitauthorPentelute, Bradley L.
dc.relation.journalNature Communicationsen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-02-01T16:12:57Z
dspace.orderedauthorsCho, Choi-Fong; Wolfe, Justin M.; Fadzen, Colin M.; Calligaris, David; Hornburg, Kalvis; Chiocca, E. Antonio; Agar, Nathalie Y. R.; Pentelute, Bradley L.; Lawler, Sean E.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-9811-4396
dc.identifier.orcidhttps://orcid.org/0000-0002-1003-6045
dc.identifier.orcidhttps://orcid.org/0000-0002-4139-9578
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record